Search Results - "Belisle, Sylvain"

Refine Results
  1. 1
  2. 2

    In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept by Rochon, Antoine G., Bélisle, Sylvain, Couture, Pierre, Fortier, Annik, Lebon, Jean-Sébastien, Deschamps, Alain

    “…In vivo protamine titration (IVPT) is based on the observation of a plateau on the decay curve of the celite activated clotting times (ACTs) during protamine…”
    Get full text
    Journal Article
  3. 3

    Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients: A Review of 17 Randomized Controlled Trials by Hardy, Jean-François, MD, FRCPC, Bélisle, Sylvain, MD, FRCPC, Van der Linden, Philippe, MD, PhD

    Published in The Annals of thoracic surgery (01-09-2008)
    “…We reassess all published randomized controlled trials that have evaluated the hemostatic efficacy or safety of recombinant activated factor VII (rFVIIa), or…”
    Get full text
    Journal Article
  4. 4

    “CAPS” Cardiac Acute Pain Services—A Nationwide Survey From Canada by Cogan, Jennifer, MD, FRCPC, Eipe, Naveen, MBBS, MD, Vargas-Schaffer, Grisell, MD, Ouimette, Marie-France, RN, MSc, Belisle, Sylvain, MD, FRCPC

    “…Objectives Acute Pain Services (APS) are well-established worldwide; however, their availability and use in cardiac surgery units are less widespread and, even…”
    Get full text
    Journal Article
  5. 5

    Antithrombotic therapy in cardiac surgery by Vincentelli, André, Jude, Brigitte, Bélisle, Sylvain

    Published in Canadian journal of anesthesia (01-06-2006)
    “…To review the perioperative management of antithrombotic therapy in cardiac surgery, including the management of cardiopulmonary bypass (CPB) and off-pump…”
    Get full text
    Journal Article
  6. 6

    Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery by Haché, Manon, Denault, André, Bélisle, Sylvain, Robitaille, Danielle, Couture, Pierre, Sheridan, Peter, Pellerin, Michel, Babin, Denis, Noël, Nicolas, Guertin, Marie-Claude, Martineau, Raymond, Dupuis, Jocelyn

    “…Objective: Pulmonary hypertension is commonly found in patients undergoing valvular surgery and can be worsened by cardiopulmonary bypass. Inhaled epoprostenol…”
    Get full text
    Journal Article
  7. 7

    Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery by PIQUETTE, Dominique, DESCHAMPS, Alain, BELISLE, Sylvain, PELLERIN, Michel, LEVESQUE, Sylvie, TARDIF, Jean-Claude, DENAULT, André Y

    Published in Canadian journal of anesthesia (01-09-2007)
    “…To determine whether or not intravenous nitroglycerin (IV NTG) can prevent a decrease in near-infrared spectroscopy (NIRS) values during cardiopulmonary bypass…”
    Get full text
    Journal Article
  8. 8

    Efficacy and safety of activated recombinant factor VII in cardiac surgical patients by Hardy, Jean-François, Bélisle, Sylvain, Van der Linden, Philippe

    Published in Current opinion in anaesthesiology (01-02-2009)
    “…Excessive bleeding is a common and morbid problem after cardiac surgery. There is no doubt a need for an effective and safe hemostatic agent in order to…”
    Get full text
    Journal Article
  9. 9

    Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities by Belisle, Sylvain, Hardy, Jean-François

    Published in The Annals of thoracic surgery (01-12-1996)
    “…Background. Several patient-, procedure-, and prescriber-related factors are thought to influence the decision to administer allogeneic blood products. We…”
    Get full text
    Journal Article
  10. 10

    Erythropoietic Response to Two Epoetin alfa Regimens in Critically Ill Patients: A Pilot Study by Darveau, Martin, Notebaert, Éric, Denault, André Y., Williamson, David R., Albert, Martin, Bélisle, Sylvain, Lachaine, Jean

    Published in Pharmacotherapy (01-11-2006)
    “…Study Objective. To compare the erythropoietic responses and tolerability of two recombinant human erythropoietin (EPO) regimens. Design. Prospective,…”
    Get full text
    Journal Article
  11. 11

    Prevalence, characteristics, and predictors of chronic nonanginal postoperative pain after a cardiac operation: A cross-sectional study by Taillefer, Marie-Christine, Carrier, Michel, Bélisle, Sylvain, Levesque, Sylvie, Lanctôt, Hélène, Boisvert, Anne-Marie, Choinière, Manon

    “…This study was designed to assess the prevalence, characteristics, effect, and predictors of chronic postoperative pain 1 to 3 years after cardiac surgery…”
    Get full text
    Journal Article
  12. 12

    Recombinant human erythropoietin use in intensive care by Darveau, M, Notebaert, E, Denault, AY, Belisle, S

    Published in The Annals of pharmacotherapy (01-06-2002)
    “…OBJECTIVE: To review the literature concerning the role of recombinant human erythropoietin (rHuEPO) in reducing the need for transfusion in critically ill…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: A single-centre retrospective study by Faraoni, David, Willems, Ariane, Romlin, Birgitta S, Belisle, Sylvain, Van der Linden, Philippe

    Published in European journal of anaesthesiology (01-05-2015)
    “…BACKGROUNDAlthough rotational thromboelastometry (ROTEM) is increasingly used to guide haemostatic therapy in a bleeding patient, there is a paucity of data…”
    Get full text
    Journal Article
  15. 15

    Importance of Relative Pulmonary Hypertension in Cardiac Surgery: The Mean Systemic-to-Pulmonary Artery Pressure Ratio by Robitaille, Arnaud, Denault, André Y., Couture, Pierre, Bélisle, Sylvain, Fortier, Annik, Guertin, Marie-Claude, Carrier, Michel, Martineau, Raymond

    “…Objective: To determine the importance of the mean arterial pressure-to-mean pulmonary artery pressure ratio (MAP/MPAP) in cardiac surgical patients. Design:…”
    Get full text
    Journal Article
  16. 16

    Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants by Faraoni, David, Levy, Jerrold H, Albaladejo, Pierre, Samama, Charles-Marc

    Published in Critical care (London, England) (29-04-2015)
    “…Perioperative management of patients treated with the non-vitamin K antagonist oral anticoagulants is an ongoing challenge. Due to the lack of good clinical…”
    Get full text
    Journal Article
  17. 17

    Can peripheral venous pressure be interchangeable with central venous pressure in patients undergoing cardiac surgery? by DESJARDINS, Roger, DENAULT, André Y, BELISLE, Sylvain, CARRIER, Michel, BABIN, Denis, LEVESQUE, Sylvie, MARTINEAU, Raymond

    Published in Intensive care medicine (01-04-2004)
    “…Pressure measurements at the level of the right atrium are commonly used in clinical anesthesia and the intensive care unit (ICU). There is growing interest in…”
    Get full text
    Journal Article
  18. 18

    Perioperative pain management barriers in cardiac surgery: Should we persevere? by Cogan, Jennifer, Ouimette, Marie-France, Yegin, Zeynep, Ferland, Véronique, Vargas, Grisell, Lambert, Jean, Rochon, Antoine G., Belisle, Sylvain

    Published in Applied nursing research (01-06-2017)
    “…•Considerable efforts are deployed by hospital personnel to educate patients.•Patients remain misinformed about risks and benefits of adequate pain…”
    Get full text
    Journal Article
  19. 19

    Reproductibilité et interchangeabilité du Thromboélastographe®, Sonoclot® et du temps de coagulation activé (Hémochron®), en chirurgie cardiaque by FORESTIER, Francois, BELISLE, Sylvain, CONTANT, Chantal, HAREL, Francois, JANVIER, Gérard, HARDY, Jean-Francois

    Published in Canadian journal of anesthesia (01-10-2001)
    “…ObjectifMalgré une utilisation courante, la reproductibilité des mesures du Thromboélastographe® (TEG), du Sonoclot® (SCT), et de l’Hémochron® mesurant le…”
    Get full text
    Journal Article
  20. 20